Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously-Reference-Cited by-同舟云学术

Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously

Published:2019-11-29 Issue:3 Volume:179 Page:615-629
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Hii Ling-Wei,Chung Felicia Fei-Lei,Soo Jaslyn Sian-Siu,Tan Boon Shing,Mai Chun-Wai,Leong Chee-Onn^ORCID

Funder

Malaysia Ministry of Education

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05504-5.pdf

Reference72 articles.

1. Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23(10):1124–1134. https://doi.org/10.1038/nm.4409

2. Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, Zhou A, Eyob H, Balakrishnan S, Wang CY, Yaswen P, Goga A, Werb Z (2015) Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526(7571):131–135. https://doi.org/10.1038/nature15260

3. Zhu Y, Zhang X, Liu Y, Zhang S, Liu J, Ma Y, Zhang J (2012) Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo. Tumor Biol 33(5):1349–1362

4. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E, Zhang Y (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci 104(41):16158–16163

5. Boyer M, Cheng T (2008) The CDK inhibitors: potential targets for therapeutic stem cell manipulations? Gene Ther 15(2):117

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma;Journal of Cellular and Molecular Medicine;2024-05

2. Investigation of the effect of belinostat on MCF-7 breast cancer stem cells via the Wnt, Notch, and Hedgehog signaling pathway;Saudi Medical Journal;2024-02

3. Searching for Essential Genes and Targeted Drugs Common to Breast Cancer and Osteoarthritis;Combinatorial Chemistry & High Throughput Screening;2024-02

4. Role of cancer stem cell ecosystem on breast cancer metastasis and related mouse models;Zoological Research;2024

5. Epigenetic modification: key regulator of reprogramming in cancer stem cells;Cancer Stem Cells and Signaling Pathways;2024